Clinical Trials | May 21, 2024
Modular ATP study of the mCRM System meets primary safety and efficacy endpoints
Additional data from APPRAISE ATP trial reinforce modular therapy approach
Additional data from APPRAISE ATP trial reinforce modular therapy approach
The CALINA study tested a new ratio and dose of Coartem to account for metabolic differences in babies under 5 kg
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
The survey inspected ambulances operating throughout the city
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
Subscribe To Our Newsletter & Stay Updated
